BE837211A - Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline - Google Patents

Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline

Info

Publication number
BE837211A
BE837211A BE6045314A BE6045314A BE837211A BE 837211 A BE837211 A BE 837211A BE 6045314 A BE6045314 A BE 6045314A BE 6045314 A BE6045314 A BE 6045314A BE 837211 A BE837211 A BE 837211A
Authority
BE
Belgium
Prior art keywords
gammaglobulin
tolerance
improving
intravenous injection
intravenous
Prior art date
Application number
BE6045314A
Other languages
English (en)
Inventor
W Schneider
D Wolter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE837211A publication Critical patent/BE837211A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE6045314A 1975-01-02 1975-12-30 Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline BE837211A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen

Publications (1)

Publication Number Publication Date
BE837211A true BE837211A (fr) 1976-06-30

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6045314A BE837211A (fr) 1975-01-02 1975-12-30 Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline

Country Status (20)

Country Link
JP (1) JPS5512001B2 (fr)
AT (1) AT344883B (fr)
AU (1) AU505416B2 (fr)
BE (1) BE837211A (fr)
CA (1) CA1058075A (fr)
DD (1) DD121875A5 (fr)
DE (1) DE2500076C3 (fr)
DK (1) DK144679C (fr)
EG (1) EG11987A (fr)
ES (1) ES443982A1 (fr)
FR (1) FR2296429A1 (fr)
GB (1) GB1495159A (fr)
IE (1) IE43449B1 (fr)
IL (1) IL48766A (fr)
IN (1) IN143525B (fr)
NL (1) NL179824C (fr)
PL (1) PL99599B1 (fr)
SE (1) SE437470B (fr)
SU (1) SU576898A3 (fr)
ZA (1) ZA758050B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (fr) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Support de médicament en hydroxyalkylamidon
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
DE3271181D1 (en) * 1982-02-08 1986-06-19 Schweiz Serum & Impfinst Intravenously administrable human immunoglobuline and process for its preparation
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
DK1976877T4 (en) 2005-11-30 2017-01-16 Abbvie Inc Monoclonal antibodies to amyloid beta protein and uses thereof
PL1954718T3 (pl) 2005-11-30 2015-04-30 Abbvie Inc Przeciwciała skierowane przeciwko A globulomerowi, ich reszty wiążące antygeny, odpowiednie hybrydomy, kwasy nukleinowe, wektory, komórki gospodarze, sposoby wytwarzania tych przeciwciał, kompozycje zawierające te przeciwciała, zastosowania tych przeciwciał i sposoby stosowania tych przeciwciał
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
JP2013523182A (ja) 2010-04-15 2013-06-17 アボット・ラボラトリーズ アミロイドベータ結合タンパク質
EP2603524A1 (fr) 2010-08-14 2013-06-19 AbbVie Inc. Protéines de liaison bêta-amyloïdes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (fr) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
ZA738779B (en) * 1972-11-27 1974-10-30 Baxter Laboratories Inc Production of gamma globulin
JPS49101516A (fr) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
IE43449L (en) 1976-07-02
JPS5191321A (en) 1976-08-10
DK144679C (da) 1982-10-11
AU505416B2 (en) 1979-11-22
AT344883B (de) 1978-08-10
NL179824C (nl) 1986-11-17
DE2500076A1 (de) 1976-07-08
FR2296429A1 (fr) 1976-07-30
NL179824B (nl) 1986-06-16
DK144679B (da) 1982-05-10
NL7514627A (nl) 1976-07-06
FR2296429B1 (fr) 1978-12-01
SE437470B (sv) 1985-03-04
ES443982A1 (es) 1977-07-16
DE2500076C3 (de) 1982-11-18
JPS5512001B2 (en) 1980-03-29
DE2500076B2 (de) 1979-02-22
GB1495159A (en) 1977-12-14
IN143525B (fr) 1977-12-17
DK584375A (da) 1976-07-03
IL48766A0 (en) 1976-02-29
AU8792175A (en) 1977-07-14
SU576898A3 (ru) 1977-10-15
IL48766A (en) 1979-11-30
ZA758050B (en) 1976-12-29
SE7514388L (sv) 1976-07-05
DD121875A5 (fr) 1976-09-05
CA1058075A (fr) 1979-07-10
ATA981675A (de) 1977-12-15
EG11987A (en) 1981-12-31
PL99599B1 (pl) 1978-07-31
IE43449B1 (en) 1981-02-25

Similar Documents

Publication Publication Date Title
BE837211A (fr) Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline
BE855192A (fr) Procede de production d'acides phosphinico-carboxyliques aliphatiques substitues
FR2328689A1 (fr) Procede de preparation d'acides a-arylpropioniques substitues sur le noyau
FR2318131A1 (fr) Procede de production d'hydrocarbures olefiniques
BE844344A (fr) Procede de cyclisation pour la formation d'un noyau cepheme
LU79846A1 (fr) Procede de production d'une preparation de gamma globuline
RO72349A (fr) Procede pour la preparation des derives d'imidazole a action pharmacologique
FR2321465A1 (fr) Procede de preparation d'hydrocarbures insatures
FR2313447A1 (fr) Procede de production d'une boisson alcoolique
FR2316040A1 (fr) Procede pour l'usinage par etincelage erosif
FR2351922A1 (fr) Procede pour ameliorer la resistance d'un verre de scellement
BE851151R (fr) Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline
RO66216A (fr) Procede pour la production d'energie
FR2317760A1 (fr) Procede pour la production d'ampoules a vide
BE835023A (fr) Procede ameliore pour produire de l'urokinase
BE846708A (fr) Procede de production d'un alcane-polyol
RO74667A (fr) Procede pour la preparation d'acides 7-betha(d-2-amino-2-(alkylesulfonyleaminophenyle)-acetyleamino)-3-alcoxy-3-cephem-4-carboxyliques
FR2299869A1 (fr) Procede de preparation d'acides (
FR2329658A1 (fr) Nouveau procede de preparation d'imidazoles substitues
BE865480A (fr) Procede pour la preparation d'acides naphtylaminohydroxysulfoniques
PT64691B (fr) Procede pour la preparation d'acides 6,11-di-hydro-11-oxo-dibenz /b,e/ oxepin-alcanoiques
BE871961A (fr) Procede ameliore pour la production d'alkylene-glycols
FR2352879A1 (fr) Procede pour la production d'
BE821725A (fr) Procede pour la preparation d'acides alpha-hydroxy anthraquinone-beta-sulfonique
BE841810A (fr) Procede pour accelerer la filtration de goudrons de distillation lente

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ARMOUR PHARMACEUTICAL CY

Effective date: 19891231